Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous MSCs in Severe Multiple Sclerosis
NCT00781872Phase 2Completed
- Sponsor
- Hadassah Medical Organization
- Start
- Oct 2006
- Primary completion
- Dec 2009
- Modality
- Stem Cell Therapies
01
Overview
A Phase 2 trial of mesenchymal stem cells in multiple sclerosis (MS), sponsored by Hadassah Medical Organization. Started Oct 2006; status: completed.
02
Drugs
mesenchymal stem cells
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00781872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00781872.